A high throughput assay to identify novel chromatin factors that regulate DNA repair
鉴定调节 DNA 修复的新型染色质因子的高通量测定
基本信息
- 批准号:9767137
- 负责人:
- 金额:$ 21.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2020-08-31
- 项目状态:已结题
- 来源:
- 关键词:AmplifiersAntibodiesBindingBiochemicalBiological AssayBiological ProcessCell divisionCell physiologyCellsChromatinChromatin Remodeling FactorDNADNA BindingDNA Binding DomainDNA DamageDNA Double Strand BreakDNA RepairDNA Repair PathwayDNA biosynthesisDNA lesionDNA-Binding ProteinsDiseaseEukaryotic CellExclusionExposure toGene MutationGenerationsGeneticGenetic MaterialsGenetic TranscriptionGenomeGrantHistone AcetylationHistonesImageImmunologicsKineticsLasersLeadLibrariesLifeMalignant NeoplasmsMeasuresMethodologyMicroscopeMonitorNerve DegenerationNucleosomesOrganismPeptidesPlayProcessProteinsReaderRecruitment ActivityReporterResolutionRoleSecureSignal PathwaySiteStructureSyndromeSystemTestingTransferenceValidationVariantWorkbasecDNA Librarychromatin remodelingexperiencegenetic informationgenotoxicityhigh throughput screeninghigh throughput technologyhistone modificationimaging approachnew technologynovelquantitative imagingrecruitrepairedresponsescreeningsensor
项目摘要
Damage to our DNA poses one of the most direct threats to both the ability of our cells to function
normally, as well as our ability to faithfully transmit genetic information to our progeny. Our cells
experience a significant amount of spontaneous DNA lesions. Life, as we know it, is possible thanks
to specific DNA repair mechanisms that eukaryotic cells have evolved. Such mechanisms involved
the highly coordinated action of sensors, amplifiers and effectors that work in concert with signaling
pathways to allow efficient DNA repair, in what is known as the DNA Damage Response (DDR). Our
DNA is densely packed in chromatin, a barrier that needs to be overcome for proper recognition and
repair of DNA lesions. Indeed, chromatin dynamics has emerged as an important module in the
DDR, however the specific chromatin factors that are directly involved in the repair process remain
poorly known. In this context, advances in the field have been hampered by limited availability of
high-throughput technologies. In this exploratory grant, we will attempt to tackle these limitations by
developing both a library of chromatin factors and a microscope based-high throughput assay to
follow kinetics and recruitment of chromatin factors to DNA breaks. Specifically, in Aim 1 we will
develop a library (ChromORFeome) of chromatin factors and use a high-throughput laser breaks
assay to identify novel chromatin factors recruited to sites of DNA breaks. Aim 2 will provide proof of
principle validation of these novel identified chromatin factors. Results from this exploratory grant will
establish advanced new technologies to study the process of DNA repair and identify novel
chromatin factors that play key roles in this process.
对我们DNA的损伤是对我们细胞功能的最直接威胁之一,
正常情况下,以及我们忠实地将遗传信息传递给后代的能力。我们的细胞
会出现大量的自发性DNA损伤生命,正如我们所知,是可能的,
真核细胞进化出的特定DNA修复机制。这些机制涉及
与信号协同工作的传感器、放大器和效应器的高度协调的动作
这是一种允许有效DNA修复的途径,即所谓的DNA损伤反应(DDR)。我们
DNA密集地堆积在染色质中,这是一个需要克服的障碍,以进行正确的识别,
修复DNA损伤。事实上,染色质动力学已经成为一个重要的模块,
然而,直接参与修复过程的特定染色质因子仍然存在
知之甚少。在这方面,由于可获得的资源有限,
高通量技术。在这个探索性的补助金,我们将试图解决这些限制,
开发染色质因子文库和基于显微镜的高通量测定,
遵循染色质因子对DNA断裂的动力学和募集。具体而言,在目标1中,我们将
开发染色质因子库(ChromORFeome),并使用高通量激光断裂
检测以鉴定募集到DNA断裂位点的新型染色质因子。Aim 2将提供以下证据:
这些新鉴定的染色质因子的原理验证。这项探索性赠款的结果将
建立先进的新技术,研究DNA修复过程,
在这个过程中起关键作用的染色质因子。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Resveratrol: Friend or Foe?
白藜芦醇:朋友还是敌人?
- DOI:10.1016/j.molcel.2020.08.008
- 发表时间:2020
- 期刊:
- 影响因子:16
- 作者:Clarke,ThomasL;Mostoslavsky,Raul
- 通讯作者:Mostoslavsky,Raul
DNA repair as a shared hallmark in cancer and ageing.
- DOI:10.1002/1878-0261.13285
- 发表时间:2022-09
- 期刊:
- 影响因子:6.6
- 作者:Clarke, Thomas L.;Mostoslavsky, Raul
- 通讯作者:Mostoslavsky, Raul
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Raul Mostoslavsky其他文献
Raul Mostoslavsky的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Raul Mostoslavsky', 18)}}的其他基金
The histone deacetylase SIRT6 modulates Transcriptional pausing
组蛋白脱乙酰酶 SIRT6 调节转录暂停
- 批准号:
10317093 - 财政年份:2019
- 资助金额:
$ 21.06万 - 项目类别:
The histone deacetylase SIRT6 modulates Transcriptional pausing
组蛋白脱乙酰酶 SIRT6 调节转录暂停
- 批准号:
10080747 - 财政年份:2019
- 资助金额:
$ 21.06万 - 项目类别:
Histone tails as an energy reservoir for mitochondrial function
组蛋白尾部作为线粒体功能的能量库
- 批准号:
9063076 - 财政年份:2015
- 资助金额:
$ 21.06万 - 项目类别:
Histone tails as an energy reservoir for mitochondrial function
组蛋白尾部作为线粒体功能的能量库
- 批准号:
8927819 - 财政年份:2015
- 资助金额:
$ 21.06万 - 项目类别:
(PQB4)SIRT6 Modulates Cancer Metabolism During Aging
(PQB4)SIRT6 调节衰老过程中的癌症代谢
- 批准号:
8850410 - 财政年份:2014
- 资助金额:
$ 21.06万 - 项目类别:
The histone deacetylase SIRT6 functions as a co-repressor of Hif1 alpha in glucos
组蛋白脱乙酰酶 SIRT6 在葡萄糖中充当 Hif1 α 的共阻遏物
- 批准号:
8664883 - 财政年份:2010
- 资助金额:
$ 21.06万 - 项目类别:
Mammalian SIRT6 Is A Master Regulator Of Glucose Homeostasis
哺乳动物 SIRT6 是血糖稳态的主要调节因子
- 批准号:
8143504 - 财政年份:2010
- 资助金额:
$ 21.06万 - 项目类别:
Mammalian SIRT6 Is A Master Regulator Of Glucose Homeostasis
哺乳动物 SIRT6 是血糖稳态的主要调节因子
- 批准号:
8310218 - 财政年份:2010
- 资助金额:
$ 21.06万 - 项目类别:
Mammalian SIRT6 Is A Master Regulator Of Glucose Homeostasis
哺乳动物 SIRT6 是血糖稳态的主要调节因子
- 批准号:
8534849 - 财政年份:2010
- 资助金额:
$ 21.06万 - 项目类别:
Mammalian SIRT6 Is A Master Regulator Of Glucose Homeostasis
哺乳动物 SIRT6 是血糖稳态的主要调节因子
- 批准号:
8703675 - 财政年份:2010
- 资助金额:
$ 21.06万 - 项目类别:
相似海外基金
Novel Carbohydrate-binding Antibodies to Human Glycans Using the Lamprey System
使用 Lamprey 系统开发针对人类聚糖的新型碳水化合物结合抗体
- 批准号:
10454419 - 财政年份:2021
- 资助金额:
$ 21.06万 - 项目类别:
Novel Carbohydrate-binding Antibodies to Human Glycans Using the Lamprey System
使用 Lamprey 系统开发针对人类聚糖的新型碳水化合物结合抗体
- 批准号:
10672258 - 财政年份:2021
- 资助金额:
$ 21.06万 - 项目类别:
Novel Carbohydrate-binding Antibodies to Human Glycans Using the Lamprey System
使用 Lamprey 系统开发针对人类聚糖的新型碳水化合物结合抗体
- 批准号:
10293635 - 财政年份:2021
- 资助金额:
$ 21.06万 - 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
- 批准号:
2750554 - 财政年份:2021
- 资助金额:
$ 21.06万 - 项目类别:
Studentship
Covalent binding Antibodies as a Chemical Tool to Probe Immune Molecular Recognition
共价结合抗体作为探测免疫分子识别的化学工具
- 批准号:
565778-2021 - 财政年份:2021
- 资助金额:
$ 21.06万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Establishment of a novel serum diagnosis method for flaviviruses based on binding profiles of anti-flavivirus antibodies
基于抗黄病毒抗体结合谱建立黄病毒新型血清诊断方法
- 批准号:
20J22269 - 财政年份:2020
- 资助金额:
$ 21.06万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of Antigen Glycosylation in Mucin Binding by Monoclonal Antibodies
抗原糖基化在单克隆抗体粘蛋白结合中的作用
- 批准号:
10045898 - 财政年份:2020
- 资助金额:
$ 21.06万 - 项目类别:
Do anti-DNA antibodies play a role in the pathogenesis of systemic lupus erythematosus by binding/entering live cells?
抗 DNA 抗体是否通过结合/进入活细胞在系统性红斑狼疮的发病机制中发挥作用?
- 批准号:
16K08929 - 财政年份:2016
- 资助金额:
$ 21.06万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
N-Terminally fluorescent-labeled antibodies that show fluorescence change upon antigen-binding
N 末端荧光标记抗体,在抗原结合时显示荧光变化
- 批准号:
15K13739 - 财政年份:2015
- 资助金额:
$ 21.06万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
(i) Identification of single-molecule protein complexes involved in cellular transport of prosthetic groups (Moco and heme) (ii) Generation of monoclonal antibodies directed against protein motifs involved in binding prosthetic groups
(i) 鉴定参与假体基团(Moco 和血红素)细胞运输的单分子蛋白复合物 (ii) 生成针对参与结合假体基团的蛋白基序的单克隆抗体
- 批准号:
226653713 - 财政年份:2012
- 资助金额:
$ 21.06万 - 项目类别:
Research Units